Research and Markets: The Global Market for Fixed-Dose Combination Drugs Research Report

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/3kk5zg/the_global_market) has announced the addition of the "The Global Market for Fixed-Dose Combination Drugs" report to their offering.

Fixed-dose combination drugs have been used for some time in certain therapeutic categories such as antihypertensives, although they were often reserved for second- or third-line therapy. With the revolution in the survival rates of patients suffering from human immunodeficiency virus (HIV) infection that occurred with the implementation of fixed-drug combination products for this, this delivery technology received a boost of confidence as well as an influx of creative applications to other diseases.

For the past several years, a number of fixed-dose combination drugs have been introduced for a variety of diseases, some for the first time in a particular disease category. With this in mind, this report focuses on the impact of fixed-dose combination drug technology on various therapeutic categories, as well as providing assessments and projections of this technology overall and the impact on the patient compliance and effectiveness.

Specifically the aim of this report is to provide a range of information - from detailed market analyses through industry trends - to quantify and qualify the market for fixed-dose combination drugs for the treatment of selected major diseases. Forecasts and trends are gleaned from industry sources as well as from considered assessment of available and emerging technologies. The report develops forecasts for selected disease categories of the fixed-dose combination drug market from 2012 through 2017 and examines strategies employed by biotechnology companies and pharmaceutical firms to develop and market products in this market sector

Companies Mentioned

- Abbott Laboratories

- Astrazeneca Plc

- Aptalis Pharma

- Bristol-Myers Squibb

- Gilead Sciences Inc

- Glaxosmithkline Plc

- Horizon Pharma Usa

- Horizon Pharma Gmbh

- Merck & Company, Inc

- Novartis Ag

- Orexigen Therapeutics, Inc

- Pfizer Inc

- Skyepharma Plc

For more information visit http://www.researchandmarkets.com/research/3kk5zg/the_global_market

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals